Skip directly to search
Skip directly to A to Z list
Skip directly to navigation
Skip directly to page options
Skip directly to site content
Start of Search Controls
Search Form Controls
Search The CDC
submit
CDC A-Z Index
MENU
CDC A-Z
SEARCH
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Search Form Controls
Search The CDC
submit
CDC A-Z Index
Public Health Genomics and Precision Health Knowledge Base (v9.0)
PHGKB
About
Public Health Genomics Branch
PHGKB Weekly Horizon Scan
Genomics Precision Health Scan
Advanced Molecular Detection Clips
Non-Genomics Precision Health Scan
CDC-authored Publications Scan
Specialized PHGKB
Cancer PHGKB
Diabetes PHGKB
Economic Evaluation PHGKB
Environmental Health PHGKB
Family Health History PHGKB
Health Equity PHGKB
HLBS-PopOmics
Infectious Diseases PHGKB
Implementation Science PHGKB
Neurological Disorders PHGKB
Pharmacogenomics PHGKB
Primary Immune Deficiency Diseases PHGKB
Rare Diseases PHGKB
Reproductive and Child Health PHGKB
All Databases
COVID-19 GPH (47393)
CDC/NIH Web Information Database (32181)
CDC-Authored Genomics and Precision Health Publications Database (6021)
Precision Health Database (63675)
Tier-Classified Guidelines Database (534)
Pathogen Advanced Molecular Detection Database (26775)
All of Us Reports and Publications Database (676)
Human Genome Epidemiology
Human Genome Epidemiology Literature Finder (226505)
Epigenetic Epidemiology Publications Database (22770)
Release Note
Contact Us
Precision Health Database
Precision Health Database|Search|Public Health Genomics and Precision Health Knowledge Base (PHGKB)
Last data update: Apr 25, 2024
. (Total: 63675 Documents since 2012)
All
Cancer
Diabetes
Economic
Environmental
Equity
FHH
HLBS
ID
Implementation
ND
PGx
PI
Rare
RCH
dataset
All
GPH
Non-GPH
Filtered By
:
Select to fine-tune your search
Disease
Gene
Product Type
Category
Year
Previous
Records 1 - 19 (of 19 Records)
Query Trace:
Brca[original query]>>Ethical, Legal and Social Issues (ELSI)[Category]
Medicolegal and insurance issues regarding BRCA1 and BRCA2 gene tests in high income countries.
Riccardo Oliva et al. Int J Gynecol Cancer 2024
Similar articles in PubMed
Understanding Medical Mistrust in Black Women at Risk of BRCA 1/2 Mutations.
Sutton Arnethea L et al. Journal of health disparities research and practice 2019 12(3) 35-47
Similar articles in PubMed
Bioethics and healthcare policies. The benefit of using genetic tests of BRCA 1 and BRCA 2 in elderly patients.
Fonseca Vasco et al. The International journal of health planning and management 2020 Sep
Similar articles in PubMed
Negotiating jurisdictional boundaries in response to new genetic possibilities in breast cancer care: The creation of an 'oncogenetic taskscape'.
Wright Sarah et al. Social science & medicine (1982) 2019 22526-33
Similar articles in PubMed
Pioneering Informed Consent for Return of Research Results to Breast Cancer Patients Facing Barriers to Implementation of Genomic Medicine: The Kenyan BRCA1/2 Testing Experience Using Whole Exome Sequencing.
Torrorey-Sawe Rispah et al. Frontiers in genetics 2020 11170
Similar articles in PubMed
Is Genetic Medicine Making the World Less Fair?
L Hercher, the Nation, August 23, 2019
Senior doctors call for crackdown on home genetic testing kits
H Devlin, the Guardian, July 21, 2019
International Divergence in Gene Patenting.
Nicol Dianne et al. Annual review of genomics and human genetics 2019 Feb
Similar articles in PubMed
Direct-to-Consumer Genetic Testing: The Implications of the US FDA's First Marketing Authorization for BRCA Mutation Testing.
Gill Jennifer, et al. JAMA 2018 6 0. (23) 2377-2378
Similar articles in PubMed
The FDA says you can now test yourself for cancer at home without a doctor. Here's why you shouldn't.
D Ropeik, NBC News Blog, Mar 23, 2018
The Right Not to Know: When Ignorance Is Bliss but Deadly
AM Clausen, Pultizer Center, Mar 20, 2018
Direct-to-Consumer Test for BRCA Mutations Authorized.
et al. Cancer discovery 2018 Mar
Similar articles in PubMed
Opinion: No, FDA Didnt Really Approve BRCA Test-Rather, the breast cancer mutation screen was classified as a type of medical device with obligations for the company to reduce risks to customers.
C Janssens, The Scientist, Mar 19, 2018
NSGC Responds to U.S. Food and Drug Administration Approval of Direct-to-Consumer Cancer Test that Reports Three BRCA Mutations
NSGC, Mar 6, 2018
23andMe Will Now Test for BRCA Breast-Cancer Genes It's the first FDA-authorized genetic-cancer-risk test available without a doctor's note.
S Zhang, The Atlantic, Mar 6, 2018
FDA approves new direct to consumer genetic test for 3 BRCA mutations
FORCE, Mar 6, 2018
FDA authorizes, with special controls, direct-to-consumer test that reports three mutations in the BRCA breast cancer genes,
FDA, March 6, 2018
FDA approves olaparib for germline BRCA-mutated metastatic breast cancer
FDA, Jan 12, 2018
The risk of unjustified BRCA testing after the "Angelina Jolie effect": how can we save (laboratory) medicine from the Internet?
Lippi Giuseppe et al. Clinical chemistry and laboratory medicine 2017 Jul
Similar articles in PubMed
File Formats Help:
How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?
Adobe PDF file
Microsoft PowerPoint file
Microsoft Word file
Microsoft Excel file
Audio/Video file
Apple Quicktime file
RealPlayer file
Text file
Zip Archive file
SAS file
ePub file
Page last reviewed:
Feb 1, 2024
Page last updated:
Apr 25, 2024
Content source:
Public Health Genomics Branch in the Division of Blood Disorders and Public Health Genomics
,
National Center on Birth Defects and Developmental Disabilities
TOP